Jacob M. Rowe

Active 1967–2025

Also published as
Jacob M Rowe
153
Papers
32,457
Citations
102
h-index
153
i10-index

Citations

Citations per year for Jacob M. Rowe1967: 1 citations1972: 3 citations1973: 2 citations1974: 7 citations1975: 7 citations1976: 1 citations1977: 1 citations1978: 2 citations1979: 2 citations1980: 3 citations1982: 2 citations1983: 2 citations1984: 1 citations1985: 2 citations1986: 3 citations1989: 8 citations1990: 6 citations1991: 4 citations1992: 6 citations1993: 4 citations1994: 6 citations1995: 12 citations1996: 15 citations1997: 17 citations1998: 21 citations1999: 41 citations2000: 50 citations2001: 63 citations2002: 85 citations2003: 114 citations2004: 87 citations2005: 136 citations2006: 142 citations2007: 143 citations2008: 161 citations2009: 186 citations2010: 223 citations2011: 214 citations2012: 277 citations2013: 315 citations2014: 313 citations2015: 363 citations2016: 351 citations2017: 326 citations2018: 269 citations2019: 895 citations2020: 888 citations2021: 863 citations2022: 545 citations2023: 387 citations2024: 715 citations2025: 277 citations2026: 3 citations1968–1971: no citations, so these years are not shown1981: no citations, so this year is not shown1987–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,352 citing papers, 30.3% of this breakdownChina: 775 citing papers, 7% of this breakdownGermany: 769 citing papers, 6.9% of this breakdownUnited Kingdom: 649 citing papers, 5.9% of this breakdownItaly: 633 citing papers, 5.7% of this breakdownFrance: 581 citing papers, 5.2% of this breakdownNetherlands: 381 citing papers, 3.4% of this breakdownCanada: 372 citing papers, 3.4% of this breakdownSpain: 349 citing papers, 3.1% of this breakdownJapan: 267 citing papers, 2.4% of this breakdownAustralia: 251 citing papers, 2.3% of this breakdownIsrael: 241 citing papers, 2.2% of this breakdown
0%30.3%Other 22.2%

Fields

  • Medicine70.2%
  • Biochemistry, Genetics and Molecular Biology23.4%
  • Immunology and Microbiology2.8%
  • Materials Science0.6%
  • Computer Science0.4%
  • Engineering0.3%
  • Other2.3%

Topics

  • Acute Myeloid Leukemia Research14.1%
  • Acute Lymphoblastic Leukemia research9.7%
  • Chronic Myeloid Leukemia Treatments4.9%
  • Hematopoietic Stem Cell Transplantation4.1%
  • Epigenetics and DNA Methylation3.3%
  • Retinoids in leukemia and cellular processes3%
  • Other60.9%

Coauthors

All papers

Open in search
  1. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly W. Maloney, Alessandro Rambaldi, Orietta Spinelli, Jerald P. Radich, Mark D. Minden, Jacob M. Rowe, Selina M. Luger, Mark R. Litzow, Martin S. Tallman, Janis Racevskis, Yanming Zhang, Ravi Bhatia, Jessica Kohlschmidt, Krzysztof Mrózek, Clara D. Bloomfield, Wendy Stock, Steven M. Kornblau, Hagop M. Kantarjian, Marina Konopleva, Williams E. Evans, Sima Jeha, Ching‐Hon Pui, Jun J. Yang, Elisabeth Paietta, James R. Downing, Mary V. Relling, Jinghui Zhang, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan - Nature Genetics 2019 cited by 617

  2. Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ross L. Levine - New England Journal of Medicine 2012 cited by 1,948

  3. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michelle A. Elliott, Anjali S. Advani, Dimitrios Tzachanis, Pankit Vachhani, Rupali Bhave, Elad Sharon, Richard F. Little, Harry P. Erba, Richard M. Stone, Selina M. Luger, Charles G. Mullighan, Martin S. Tallman - New England Journal of Medicine 2024 cited by 215

  4. Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Yin, Steven M. Kornblau, Stephen P. Hunger, Mignon L. Loh, Ching‐Hon Pui, Wenjian Yang, Kristine R. Crews, Kathryn G. Roberts, Jun J. Yang, Mary V. Relling, William E. Evans, Wendy Stock, Elisabeth Paietta, Adolfo A. Ferrando, Jinghui Zhang, Wolfgang Kern, Torsten Haferlach, Gang Wu, John E. Dick, Jeffery M. Klco, Claudia Haferlach, Charles G. Mullighan - Cancer Discovery 2021 cited by 188

  5. Anthracycline Dose Intensification in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 907

  6. High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wendy Stock, Stephen Kornblau, Hagop M. Kantarjian, Marina Konopleva, Elisabeth Paietta, Cheryl L. Willman, Charles G. Mullighan - Journal of Clinical Oncology 2017 cited by 449

  7. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

    Authors: , , , , , , , , , , , , , - Blood 2006 cited by 843

  8. Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2022 cited by 75

  9. Very poor long‐term survival in past and more recent studies for relapsed AML patients: The ECOG‐ACRIN experience

    Authors: , , , , , , , , , , , , , , - American Journal of Hematology 2018 cited by 156

  10. Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter H. Wiernik, Jacob M. Rowe, Martin S. Tallman, Anthony H. Goldstone, Charles G. Mullighan, Mark R. Litzow - Blood 2021 cited by 116

  11. Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2012 cited by 526

  12. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xiaotu Ma, Michael Rusch, Pankaj Gupta, Kristy Boggs, Bhavin Vadodaria, James Dalton, Yanling Liu, Marcus Valentine, Li Ding, Charles Lu, Robert S. Fulton, Lucinda Fulton, Yashodhan Tabib, Kerri Ochoa, Meenakshi Devidas, Deqing Pei, Cheng Cheng, Jun J. Yang, William E. Evans, Mary V. Relling, Ching‐Hon Pui, Sima Jeha, Richard C. Harvey, I-Ming L. Chen, Cheryl L. Willman, Guido Marcucci, Clara D. Bloomfield, Jessica Kohlschmidt, Krzysztof Mrózek, Elisabeth Paietta, Martin S. Tallman, Wendy Stock, Matthew C. Foster, Janis Racevskis, Jacob M. Rowe, Selina M. Luger, Steven M. Kornblau, Sheila Shurtleff, Susana C. Raimondi, Elaine R. Mardis, Richard K. Wilson, John E. Dick, Stephen P. Hunger, Mignon L. Loh, James R. Downing, Charles G. Mullighan - Nature Genetics 2016 cited by 318

  13. Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John E. Dick, Laura J. Janke, Junmin Peng, Kiran Kodali, Vishwajeeth Pagala, Jaeki Min, Anand Mayasundari, Richard T. Williams, Cheryl L. Willman, Jacob M. Rowe, Selina M. Luger, Ross A. Dickins, R. Kiplin Guy, Taosheng Chen, Charles G. Mullighan - Cancer Cell 2015 cited by 215

  14. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Burke, Francesca Gianni, Orietta Spinelli, Jerald P. Radich, Mark D. Minden, Anthony V. Moorman, Bella Patel, Adele K. Fielding, Jacob M. Rowe, Selina M. Luger, Ravi Bhatia, Ibrahim Aldoss, Stephen J. Forman, Jessica Kohlschmidt, Krzysztof Mrózek, Guido Marcucci, Clara D. Bloomfield, Wendy Stock, Steven M. Kornblau, Hagop M. Kantarjian, Marina Konopleva, Elisabeth Paietta, Cheryl L. Willman, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan - Nature Communications 2016 cited by 296

  15. Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2020 cited by 71

  16. All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

    Authors: , , , , , , , , , , - New England Journal of Medicine 1997 cited by 1,093

  17. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

    Authors: , , , , , , , , , , , , , , , , , - Blood 2006 cited by 748

  18. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)

    Authors: , , , , , , , , , , , , , , , , - Blood 2009 cited by 416

  19. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott A Armstrong, Stefan Kubicek, Philipp B. Staber, Mithat Gönen, Elisabeth Paietta, Ari Melnick, Stephen D. Nimer, Siddhartha Mukherjee, Ross L. Levine - Nature Medicine 2016 cited by 249

  20. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nasheed Hossain, Christopher G. Kanakry, Mohamed A. Kharfan‐Dabaja, Nandita Khera, Yener Koç, Hillard M. Lazarus, Jong Wook Lee, Johan Maertens, Rodrigo Martino, Joseph P. McGuirk, Reinhold Munker, Hemant S. Murthy, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Neil Palmisiano, Sagar S. Patel, Joseph Pidala, Rebecca L. Olin, Richard F. Olsson, Betül Oran, Olle Ringdén, David A. Rizzieri, Jacob M. Rowe, Mary Lynn Savoie, Kirk R. Schultz, Sachiko Seo, Brian C. Shaffer, Anurag K. Singh, Melhem Solh, Keith Stockerl‐Goldstein, Leo F. Verdonck, John L. Wagner, Edmund K. Waller, Marcos de Lima, Brenda M. Sandmaier, Mark R. Litzow, Dan Weisdorf, Rizwan Romee, Wael Saber - Blood Advances 2019 cited by 128

  21. Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 375

  22. Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999

    Authors: , , , , , , , , , - Blood 2010 cited by 236

  23. Acute lymphoblastic leukemia displays a distinct highly methylated genome

    Authors: , , , , , , , , , , , , , , , , , - Nature Cancer 2022 cited by 52

  24. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

    Authors: , , , , , , , , , , , , , , , , , , - Blood 2007 cited by 782